Coronavirus vaccine tested in China shows promise after early study in 100 people

A potential coronavirus vaccine developed in China appeared safe and able to generate an immune response after an early trial in more than 100 people, according to a new study.

The vaccine, called Ad5-nCoV, is being developed by the Chinese company CanSino Biologics, and was one of the first coronavirus vaccines to enter early human trials back in March. Now, there are more than 100 different coronavirus vaccines in development worldwide, with at least eight of those in the process of human trials.

Leave a Reply

Your email address will not be published. Required fields are marked *